Adult Stem Cell Assay Market Report 2024

This Adult Stem Cell Assay market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The adult stem cell assay market size has grown rapidly in recent years. It will grow from $8.88 billion in 2023 to $10.28 billion in 2024 at a compound annual growth rate (CAGR) of 15.7%. The growth during the historic period can be attributed to the rise of regenerative medicine, a surge in research interest, expanding applications in medicine, the increasing prevalence of chronic diseases, and a rise in the approval of clinical trials.

The adult stem cell assay market size is expected to see rapid growth in the next few years. It will grow to $18.52 billion in 2028 at a compound annual growth rate (CAGR) of 15.9%. The anticipated growth during the forecast period can be attributed to several factors, the increasing aging population, the growing emphasis on personalized medicine, rising investments and infrastructure development, heightened demand for regenerative medicine, and increasing expenditures on research activities. Key trends expected during this period include the integration of artificial intelligence and automation, the adoption of organ-on-a-chip technologies, advancements in tissue engineering, drug discovery and development, and progress in clinical research.

The increasing demand for regenerative medicine is expected to drive the growth of the adult stem cell assay market. Regenerative medicine involves biomedical techniques aimed at replacing, repairing, or restoring the normal function of cells, tissues, or organs that have been damaged by aging, disease, trauma, or congenital conditions. The aging global population is fueling the demand for regenerative medicine, particularly for treatments addressing age-related diseases such as arthritis and cardiovascular conditions. Adult stem cell assays are essential for assessing cell differentiation, proliferation, migration, and interactions, which are crucial for evaluating cell viability and effectiveness in regenerative medicine, including stem cell therapies. For example, a report by the American Society of Gene & Cell Therapy (ASGCT) and Citeline published in July 2023 indicated that the number of gene therapies in Phase II increased by 5% from 247 at the end of Q1 2023 to 260 by the end of Q2. This growing focus on regenerative medicine is propelling the adult stem cell assay market.

Leading companies in the adult stem cell assay market are developing advanced, ready-to-use organoid tubule assay models to enhance the predictability of therapeutic outcomes and accelerate the development of personalized treatments. These pre-assembled systems utilize organoids derived from adult stem cells and are designed for immediate research application. For instance, in March 2023, MIMETAS, a Netherlands-based provider of organ-on-a-chip-based disease models, introduced the OrganoReady product line. This product includes a fully prepared adult stem cell (ASC)-derived organoid tubule-based assay model, which simplifies cell culture and tissue creation, facilitating rapid experimentation. The OrganoReady model features ASC-derived colon and kidney organoid tubules, optimized for mechanistic toxicology and drug-induced organ injury studies. With 64 organoids per plate, it supports medium- to high-throughput screening, offering a robust platform for adult stem cell assays.

In January 2024, STEMCELL Technologies Inc., a biotechnology firm based in Canada, purchased Propagenix Inc. for an undisclosed sum. This acquisition is intended to strengthen STEMCELL Technologies' presence in the adult stem cell assay market by incorporating Propagenix's technologies and expertise, which will improve the creation of innovative research tools and solutions. Propagenix Inc. is a biotechnology company located in the United States.

Major companies operating in the adult stem cell assay market are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Lonza Group AG, Sartorius AG, Sigma Aldrich Chemicals Pvt. Ltd., STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Abcam Plc, R&D Systems Inc., BioLegend Inc., Sino Biological Inc., Cell Signaling Technology, Inc., Enzo Biochem Inc., Creative Bioarray, ScienCell Research Laboratories Inc., Cell Biolabs Inc., Abnova Corporation, American Type Culture Collection, AMSBIO LLC.

North America was the largest region in the adult stem cell assay market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adult stem cell assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the adult stem cell assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

An adult stem cell assay is a laboratory test used to analyze the behavior and characteristics of adult stem cells, which are undifferentiated cells with the ability to self-renew and differentiate into specific tissue types. The primary aim of the assay is to evaluate the stem cells' capacity to regenerate tissues, their potential for differentiation, and their therapeutic efficacy in treating diseases.

The main types of adult stem cell assays include viability or cytotoxicity, isolation and purification, cell identification, proliferation, differentiation, function, and apoptosis. The viability or cytotoxicity assay assesses the health of stem cells by measuring cell survival and their responses to various conditions to determine the effects of potential toxins. These assays are utilized in regenerative medicine, therapy development, drug discovery, and clinical research, serving various end-users such as government research institutes, private research organizations, and industry research facilities.

The adult stem cell assays market research report is one of a series of new reports that provides adult stem cell assays market statistics, including the adult stem cell assays industry global market size, regional shares, competitors with the adult stem cell assays market share, detailed adult stem cell assays market segments, market trends, and opportunities, and any further data you may need to thrive in the adult stem cell assays industry. These adult stem cell assays market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The adult stem cell assay market consists of revenues earned by entities by providing services such as colony-forming unit (CFU) assays, migration and invasion assays, toxicity screening, multipotency assays, gene editing, and genetic manipulation. The market value includes the value of related goods sold by the service provider or included within the service offering. The adult stem cell assay market also includes sales of incubators, centrifuges, microscopes, plate readers, and PCR machines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.